rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1999-8-11
|
pubmed:abstractText |
To investigate the immunopathological significance of CD40/CD40 ligand system for B cell hyperactivation in SLE patients, the expression and the function of CD40 on B cells were compared with those of normal controls.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0961-2033
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
227-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10342716-Antigens, CD40,
pubmed-meshheading:10342716-Autoantibodies,
pubmed-meshheading:10342716-B-Lymphocytes,
pubmed-meshheading:10342716-CD40 Ligand,
pubmed-meshheading:10342716-Case-Control Studies,
pubmed-meshheading:10342716-DNA,
pubmed-meshheading:10342716-Humans,
pubmed-meshheading:10342716-Leucine Zippers,
pubmed-meshheading:10342716-Lupus Erythematosus, Systemic,
pubmed-meshheading:10342716-Lymphocyte Activation,
pubmed-meshheading:10342716-Membrane Glycoproteins,
pubmed-meshheading:10342716-Recombinant Fusion Proteins,
pubmed-meshheading:10342716-Thymidine
|
pubmed:year |
1999
|
pubmed:articleTitle |
Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus.
|
pubmed:affiliation |
Institute of Rheumatology, Tokyo Women's Medical University, Japan. vj5m-hrgi@asahi-net.or.jp
|
pubmed:publicationType |
Journal Article,
In Vitro
|